Dilek Erdem
Bakirkoey, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.
Journal: Immunotherapy
Published: September 02, 2026
Adding immunotherapy to chemotherapy may improve survival after SCLC transformation in EGFR-mutant NSCLC: a multicenter real-world study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 14, 2026
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.
Journal: Clinical genitourinary cancer
Published: May 03, 2026
Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer.
Journal: Experimental hematology & oncology
Published: February 19, 2026
Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.
Journal: Breast (Edinburgh, Scotland)
Published: January 21, 2026
Antibody-drug conjugate sequencing in HER2-positive metastatic breast cancer: Real-world outcomes of trastuzumab deruxtecan with and without prior T-DM1 exposure.
Journal: Breast (Edinburgh, Scotland)
Published: January 21, 2026
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study.
Journal: Therapeutic advances in medical oncology
Published: December 19, 2025
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.
Journal: The New England journal of medicine
Published: October 22, 2025
Beyond CDK4/6 Inhibition: Current Strategies in Hormone Receptor-Positive Metastatic Breast Cancer.
Journal: Current treatment options in oncology
Published: October 19, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.
Journal: Future oncology (London, England)
Published: October 17, 2025
Lung Metastatic Ameloblastoma: A Hidden Cause of Pulmonary Nodules.
Journal: Balkan medical journal
Published: September 12, 2025
First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: August 26, 2025
Last Updated: 09/26/2026